Trexquant Investment’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-270,115
| Closed | -$4.66M | – | 1826 |
|
|
2025
Q3 | $4.66M | Sell |
270,115
-857,216
| -76% | -$10.6M | 0.05% | 575 |
|
|
2025
Q2 | $10.6M | Buy |
1,127,331
+522,635
| +86% | +$4.29M | 0.12% | 228 |
|
|
2025
Q1 | $4.3M | Sell |
604,696
-62,936
| -9% | -$636K | 0.05% | 570 |
|
|
2024
Q4 | $7.78M | Buy |
+667,632
| New | +$10.4M | 0.09% | 360 |
|
|
2024
Q3 | – | Sell |
-170,828
| Closed | -$3.82M | – | 1767 |
|
|
2024
Q2 | $3.82M | Buy |
+170,828
| New | +$4.07M | 0.06% | 492 |
|
|
2022
Q4 | – | Sell |
-26,551
| Closed | -$1.49M | – | 1622 |
|
|
2022
Q3 | $1.49M | Buy |
+26,551
| New | +$1.65M | 0.05% | 420 |
|
|
2021
Q4 | – | Sell |
-11,596
| Closed | -$1.56M | – | 1527 |
|
|
2021
Q3 | $1.56M | Buy |
+11,596
| New | +$1.76M | 0.12% | 233 |
|
|
2021
Q2 | – | Sell |
-12,493
| Closed | -$1M | – | 1372 |
|
|
2021
Q1 | $1M | Buy |
+12,493
| New | +$839K | 0.09% | 283 |
|
|
2020
Q4 | – | Sell |
-44,753
| Closed | -$890K | – | 1352 |
|
|
2020
Q3 | $890K | Buy |
44,753
+9,871
| +28% | +$206K | 0.06% | 460 |
|
|
2020
Q2 | $733K | Buy |
34,882
+9,381
| +37% | +$159K | 0.05% | 518 |
|
|
2020
Q1 | $312K | Buy |
25,501
+10,561
| +71% | +$142K | 0.02% | 839 |
|
|
2019
Q4 | $219K | Buy |
14,940
+2,490
| +20% | +$34.6K | 0.01% | 877 |
|
|
2019
Q3 | $166K | Buy |
12,450
+1,093
| +10% | +$17.4K | 0.01% | 775 |
|
|
2019
Q2 | $186K | Buy |
+11,357
| New | +$179K | 0.02% | 697 |
|
|
2018
Q3 | – | Sell |
-20,301
| Closed | -$555K | – | 1119 |
|
|
2018
Q2 | $555K | Buy |
+20,301
| New | +$492K | 0.04% | 506 |
|
Other funds holding NTLA
AIM
RP
